Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Katanin catalytic subunit A1 like 1 (KATNAL1) is an ATPase and microtubule-severing enzyme, closely related to the canonical katanin p60, with approximately 66% identity and 78% conservation. It functions as part of the katanin complex and is important for cytoskeletal reorganization, particularly in processes such as spermiogenesis in Sertoli cells and various aspects of neural development and function. Loss-of-function mutations in KATNAL1 can cause male infertility (azoospermia) by disrupting Sertoli cell microtubule dynamics and sperm retention. In the central nervous system, KATNAL1 is essential for neuronal migration, brain morphology, and maintenance of motile cilia in ependymal cells, and mutations have been associated with behavioral, circadian, and neurodevelopmental phenotypes such as intellectual disability, microcephaly, and possibly schizophrenia and autism. No therapeutic drugs are currently reported to directly interact with this protein, and it is not regarded as a validated therapeutic target at present.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Katanin catalytic subunit A1 like 1 (KATNAL1).